738
Participants
Start Date
March 31, 2005
Primary Completion Date
June 30, 2008
Study Completion Date
April 30, 2015
Cyclosporine (CsA)
tablet, oral, 1st month target: 150-300 ng/mL, after 1st month target: 100-250 ng/mL, daily, 36 months (ST), 100-250 ng/mL, daily, 24 months (LT)
Belatacept LI (less intensive)
solution, IV, 10mg/kg: Days 1 and 5, Weeks 2, 4, 8 and 12, then 5 mg/kg every 4 weeks, q 4 weeks, 36 months (ST), 5 mg/kg every 4 weeks, q 4 weeks, 24 months (LT)
Belatacept MI (more intensive)
solution, IV, 10mg/kg: Days 1 and 5, Weeks 2, 4, 6, 8, 10,12, 16, 20, and 24, then 5 mg/kg every 4 weeks, q 4 weeks, 36 months (ST), 5 mg/kg every 4 weeks, q 4 weeks, 24 months (LT)
Local Institution, Vienna
Local Institution, La Plata
Local Institution, Rosario
Local Institution, Camperdown
Local Institution, Westmead
Local Institution, Leuven
Local Institution, Bern
Local Institution, Parkville
Local Institution, Durban
Local Institution, Adelaide
Local Institution, Innsbuck
Local Institution, Observatory
Local Institution, Zurich
Local Institution, Ghent
Recanati/Miller Transplantation Institute, New York
Columbia University College Of Physicians & Surgeons, New York
Local Institution, Campinas
Local Institution, Berlin
Local Institution, Distrito Federal
Local Institution, Mexico City
University Of Rochester Medical Center, Rochester
Div Of Multi-Organ Trans, Hepato-Biliary-Pancreatic Surgery, Philadelphia
Local Institution, Aguascalientes
Local Institution, Milan
Local Institution, Rio de Janeiro / Rj
Inova Transplant Center, Fairfax
Vanderbilt University Medical Center, Nashville
University Of North Carolina At Chapel Hill, Chapel Hill
Duke University Medical Center, Durham
Local Institution, Madrid
Carolinas Medical Center, Charlotte
Local Institution, Málaga
Musc, Charleston
Local Institution, Brest
Piedmont Hospital, Atlanta
Emory University Hospital, Atlanta
Local Institution, Hanover
Medical College Of Georgia, Augusta
Local Institution, Toulouse
Local Institution, Bordeaux
Local Institution, Padua
University Of Alabama At Birmingham, Birmingham
Local Institution, Grenoble
University Of Kentucky, Lexington
Local Institution, Nantes
Local Institution, Essen
Henry Ford Hospital, Transplant Institute, Detriot
Local Institution, Petah Tikva
University Of Iowa Hospitals And Clinics, Iowa City
Froedtert Memorial Lutheran Hospital, Milwaukee
University Of Wisconsin, Madison
University Of Minnesota, Minneapolis
University Of Chicago Hospitals, Chicago
Local Institution, Cuernavaca
Washington University School Of Medicine, St Louis
Local Institution, Monterrey
Local Institution, Paris
Baylor University Medical Center, Dallas
Local Institution, San Luis Potosí City
University Of Colorado Health Sciences Center, Aurora
Local Institution, Porto Alegre
Local Institution, Porto Alegre/rs
Cedars Sinai Medical Center, Los Angeles
Local Institution, Erlangen
California Institute Of Renal Research, San Diego
Loma Linda University Medical Center-Transplantation Institu, Loma Linda
Local Institution, Créteil
University Of California San Francisco Medical Center, San Francisco
Swedish Medical Center, Seattle
Sacred Heart Medical Ctr Providence Medical Research Ctr, Spokane
Local Institution, New Delhi
Local Institution, Chandigarh
Local Institution, Lucknow
Local Institution, Gujarat
Local Institution, Ahmedabad
Local Institution, Nadiād
Local Institution, Mumbai
Local Institution, Kochi
Yale University School Of Medicine-Yale New Haven Hospital, New Haven
Maine Tranplant Program, Portland
Western New England Renal & Transplant Associates, Pc, Springfield
Fletcher Allen Health Care, Burlington
Local Institution, Buenos Aires
Local Institution, Capital Federal
Local Institution, Cordoba, Crd
Local Institution, Santa Fe
Local Institution, Sao Paulo/sp
Local Institution, São Paulo
Local Institution, Edmonton
Local Institution, Halifax
Local Institution, Montreal
Local Institution, Montreal
Local Institution, Montreal
Local Institution, Saskatoon
Local Institution, Prague
Local Institution, Szeged
Local Institution, Mumbai
Local Institution, Chennai
Local Institution, Roma
Local Institution, Poznan
Local Institution, Szczecin
Local Institution, Pretoria
Local Institution, Barcelona
Local Institution, Gothenburg
Local Institution, Antalya
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY